Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William F Clark

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
Seminars in Dialysis|February 8, 2012
Thrombotic microangiopathy: current knowledge and outcomes with plasma exchangeWilliam F Clark
Kidney Research and Clinical Practice|June 13, 2019
Is high fluid intake good for the kidney?William F Clark
Annals of Internal Medicine|April 3, 2007
Correction: Plasma exchange when myeloma presents as acute renal failureWilliam F Clark
Seminars in Dialysis|July 25, 2012
The road to hell is paved with good intentionsWilliam F Clark
Kidney International. Supplement|January 31, 2009
HUS/TTP update: 2008William F Clark
Clinical Journal of the American Society of Nephrology : CJASN|December 24, 2011
Attending rounds: microangiopathic hemolytic anemia with renal insufficiencyWilliam F Clark, Ainslie Hildebrand
Journal of Gastrointestinal Cancer|December 8, 2009
A case report of gemcitabine treatment for duodenal cancer: the good (a sustained response) and the bad (life threatening refractory thrombotic thrombocytopenic purpura)Andrew Robinson, William F Clark
Clinical Journal of the American Society of Nephrology : CJASN|February 22, 2008
What have we learned about optimal induction therapy for lupus nephritis (III through V) from randomized, controlled trials?William F Clark, Jessica M Sontrop
Kidney International. Supplement|January 31, 2009
Mechanism of microthrombosis in HUSGail A Rock, William F Clark
BMJ Case Reports|August 12, 2017
Atypical haemolytic uremic syndrome (aHUS) and membranoproliferative glomerulonephritis (MPGN), different diseases or a spectrum of complement-mediated glomerular diseases?Ghada A Ankawi, William F Clark
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
Seminars in Dialysis|February 8, 2012
Thrombotic microangiopathy: current knowledge and outcomes with plasma exchangeWilliam F Clark
Kidney Research and Clinical Practice|June 13, 2019
Is high fluid intake good for the kidney?William F Clark
Annals of Internal Medicine|April 3, 2007
Correction: Plasma exchange when myeloma presents as acute renal failureWilliam F Clark
Seminars in Dialysis|July 25, 2012
The road to hell is paved with good intentionsWilliam F Clark
Kidney International. Supplement|January 31, 2009
HUS/TTP update: 2008William F Clark
Clinical Journal of the American Society of Nephrology : CJASN|December 24, 2011
Attending rounds: microangiopathic hemolytic anemia with renal insufficiencyWilliam F Clark, Ainslie Hildebrand
Journal of Gastrointestinal Cancer|December 8, 2009
A case report of gemcitabine treatment for duodenal cancer: the good (a sustained response) and the bad (life threatening refractory thrombotic thrombocytopenic purpura)Andrew Robinson, William F Clark
Clinical Journal of the American Society of Nephrology : CJASN|February 22, 2008
What have we learned about optimal induction therapy for lupus nephritis (III through V) from randomized, controlled trials?William F Clark, Jessica M Sontrop
Kidney International. Supplement|January 31, 2009
Mechanism of microthrombosis in HUSGail A Rock, William F Clark
BMJ Case Reports|August 12, 2017
Atypical haemolytic uremic syndrome (aHUS) and membranoproliferative glomerulonephritis (MPGN), different diseases or a spectrum of complement-mediated glomerular diseases?Ghada A Ankawi, William F Clark
Pageof 10